Pharmacy firms accused of money laundering
Shabbir Hussain, 03 July 2021
In a meeting of the Standing Committee on Health chaired by Nisar Ahmed Cheema, MNA Ramesh Lal alleged that some pharmaceutical companies were carrying out money laundering under the disguise of importing raw material while clearly violating laws.
Ramesha Lal, who is also a member of the health committee, said that more than a year has passed since the entire record of the case was sent to DRAP. However, he lamented, the authority has failed to explain it and present the record to the committee. Continue reading “Article: Pharmacy firms accused of money laundering”
Pandemic May Disrupt Discovery In Credit Suisse Forex Case
Dean Seal, 17 April 2020
Counsel for investors and Credit Suisse cited the COVID-19 pandemic Monday when they asked a New York federal judge to push their discovery deadlines in a suit over alleged foreign exchange market manipulation by nine weeks.
In a letter to U.S. District Judge Lorna G. Schofield, attorneys for both sides in the long-running litigation said that in light of the threat to public health posed by the novel coronavirus, as well as the disruptions it has caused in air travel, continued discovery efforts would be risky and exceedingly difficult. Continue reading “Article: Pandemic May Disrupt Discovery In Credit Suisse Forex Case”